MedTrace Logo

Endoscopic Assessment and Prediction of Microbiome-modifying Interventions

NCT03218579 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2017-07-21

No results posted yet for this study

Summary

The investigators would like to examine the extent of gut microbiome rehabilitation in healthy people after the consumption of antibiotics.

Outcomes of probiotic treatment versus bacteriotherapy will be compared.

Conditions

  • Gut Microbiome
  • Antibiotic Side Effect

Interventions

DIETARY_SUPPLEMENT

Probiotic treatment

4 weeks of probiotic treatment after 7 days of antibiotics (Metronidazole+Ciprofloxacin)

BIOLOGICAL

Bacteriotherapy

Bacteriotherapy (autologous fecal microbiota transplantation) after 7 days of antibiotics (Metronidazole+Ciprofloxacin)

Sponsors & Collaborators

  • Weizmann Institute of Science

    collaborator OTHER

  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Zamir Halpern, MD · Tel-Aviv Sourasky Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-01
Primary Completion
2019-12-30
Completion
2020-12-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03218579 on ClinicalTrials.gov